When people first hear the term glomerular hyperfiltration (GHF), many assume, “Isn’t a high filtration rate a sign that the…
Recently, SGLT2 inhibitors (SGLT2i) have been proven to provide cardiovascular and renal protection for patients with chronic kidney disease (CKD),…
🔸 Summary of Key Goals Blood Sugar Control: HbA1c 6.5–7.0%, Fasting Blood Glucose 80–130 mg/dL Blood Pressure Control: Below 130/80…
Introduction Sodium-glucose co-transporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as crucial pharmacological agents in managing…
Lupus nephritis (LN) is one of the most severe complications of systemic lupus erythematosus (SLE), affecting approximately 35–60% of patients.…
What We Know vs. What We Do: The Kidney Health Paradox 🚨 CKD treatment gap, More than 850 million people…
Impact of GLP-1 receptor agonists on cardiac structure and skeletal muscle, Recent studies have shown that GLP-1 receptor agonists (GLP-1 RA)…
SGLT2 inhibitors, Managing Type 2 Diabetes (T2D) often requires selecting medications that balance effectiveness with safety. Sodium-glucose cotransporter-2 (SGLT2) inhibitors…